CVE-2026-71286: The render-template component of ember-dynamic-render-template (addon/components/render-template.js) passes it
CVE-2026-71286 is a medium-severity flaw (CVSS 6.1) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
The render-template component of ember-dynamic-render-template (addon/components/render-template.js) passes its property directly into Ember/Glimmer's compileTemplate (from @ember/template-compilation) with no sanitization, allow-listing, or validation of the input.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.3% (top 83%) |
| CISA exploited list | No |
| Weakness | CWE-1336 |
| Published | 2026-08-05 |
| Last modified | 2026-10-23 |
Last updated 2026-10-23 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-71286?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-71286 being exploited?
CVE-2026-71286 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-71286 affect?
CVE-2026-71286 affects affected software. Severity is medium (CVSS 6.1). The render-template component of ember-dynamic-render-template (addon/components/render-template.js) passes its property directly into Ember/Glimmer's compileTemplate (from @ember/template-compilation) with no sanitization, allow-listing, o
How urgent is CVE-2026-71286?
Priority 26/100. No elevated risk signals yet.